Home/ Stocks/ HCWB

HCW Biologics Inc. Common Stock

HCWB XNAS

$0.33 +0.00 (+0.22%) ▲ 15-min delayed

Open

$0.32

High

$0.34

Low

$0.30

Volume

272.2K

Market Cap

$2.21M

About HCW Biologics Inc. Common Stock

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 35 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$54.2K	$-7,959,709	$-10.63
FY 2025	$54.2K	$-7,959,709	$-10.63
Q3 2025	$15.6K	$-4,554,336	$-2.02
Q2 2025	$6.5K	$-1,927,730	$-6.79

TickerDaily Coverage

Why Is HCW Biologics Inc. Common Stock (HCWB) Stock Up 54.7% Today?

Penny Stocks Marcus Rivera · Mar 16, 2026

HCW Biologics (HCWB) stock exploded 54.7% higher today after announcing a $1.5 million follow-on...

View All Coverage →

Get HCWB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on HCW Biologics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.